Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 2,716 shares at $17.87 ($49K) on 2024-04-08, disclosed to the SEC on 2024-04-09.
Scheduled sale ($49k) by EVP, CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |